User profiles for Nasrin Abulhasanbeigi gallehzan
 | Dr.Nasrin AbolhasanbeigiOther name: Nasrin Abulhasanbeigi Gallehzan Department of Health Economics, School of Health Management and Information Sciences … Verified email at iums.ac.ir Cited by 20 |
Cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review
Background Multiple sclerosis (MS) is a chronic, autoimmune, and inflammatory disease.
The economic burden of MS is substantial, and the high cost of Disease-modifying drugs (…
The economic burden of MS is substantial, and the high cost of Disease-modifying drugs (…
